Intestinal GSTpi deficiency exacerbates the severity of experimental hyperlipidemic acute pancreatitis
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.112363 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Jun Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, PR China; Wuxi School of Medicine, Wuxi, Jiangsu, PR China. Electronic address: wxdoctory@…. Hauptthemen laut MEDLINE: Pancreatitis, Hyperlipidemias, Mice, Inbred C57BL. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Intestinal dysfunction plays a pivotal role in the development of acute pancreatitis (AP), however, the underlying mechanisms of intestinal dysfunction on severity of hyperlipidemic acute pancreatitis (HLAP) are still unclear. Herein, we explored the role of intestinal function on the severity of HLAP. We found that HLAP patients exhibit higher lipid and inflammatory response than AP patients. Hyperlipidemia significantly elevates serum lipids and worsen pancreatic damage in AP mice. In addition, significant exacerbated intestinal barrier damage and inflammation were observed in experimental HLAP mice, as evidenced by increased serum amylase and lipase levels, and pancreatic edema. Further, RNA-Seq showed that a markedly decrease of glutathione S-transferase pi (GSTpi) in colonic tissue of HLAP mice compared with AP mice, accompanied with increased serum lipopolysaccharides level. However, colonic GSTpi overexpression by adeno-associated virus significantly attenuated intestinal damage and subsequent pancreatic inflammation in HLAP mice. Mechanistically, GSTpi mitigated HLAP-mediated colonic NLRP3 inflammasome activation and barrier dysfunction. These results suggest that intestinal GSTpi deficiency exacerbates the severity of experimental HLAP, providing new insights for the clinical treatment of HLAP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, PR China; Wuxi School of Medicine, Wuxi, Jiangsu, PR China. Electronic address: wxdoctory@163.com.
- Wuxi School of Medicine, Wuxi, Jiangsu, PR China.
- Wuxi School of Medicine, Wuxi, Jiangsu, PR China; Xinjiang Production&Construction Corps Hospital, Urumchi, Xinjiang, PR China.
- Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, PR China. Electronic address: alan89515@163.com.
- Wuxi School of Medicine, Wuxi, Jiangsu, PR China. Electronic address: xldong@jiangnan.edu.cn.
Zitieren
APA
Yang, J., Wu, B., Sha, X., Lu, H., Pan, L. L., Gu, Y., & Dong, X. (2024). Intestinal GSTpi deficiency exacerbates the severity of experimental hyperlipidemic acute pancreatitis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112363
Vancouver
Yang J, Wu B, Sha X, Lu H, Pan LL, Gu Y, et al. Intestinal GSTpi deficiency exacerbates the severity of experimental hyperlipidemic acute pancreatitis. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112363
BibTeX
@article{Yang2024,
author = {Yang, Jun and Wu, Bo and Sha, Xiaowei and Lu, Hanxiao and Pan, Li-Long and Gu, Yuanlong and Dong, Xiaoliang},
title = {Intestinal GSTpi deficiency exacerbates the severity of experimental hyperlipidemic acute pancreatitis},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.112363}
}
EUVIMED